SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
申请人:Janssen Sciences Ireland UC
公开号:US20200255373A1
公开(公告)日:2020-08-13
Inhibitors of HBV replication of Formula (I)
including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R
1
, R
2
and R
4
have the meaning as defined herein.
The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.